Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2020 2
2022 2
2023 2
2024 4
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study.
Campione E, Artosi F, Shumak RG, Giunta A, Argenziano G, Assorgi C, Balato A, Bernardini N, Brunasso AMG, Burlando M, Caldarola G, Campanati A, Carugno A, Castelli F, Conti A, Costanzo A, Cuccia A, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Donini M, Errichetti E, Esposito M, Fargnoli MC, Foti A, Fiorella C, Gargiulo L, Gisondi P, Guarneri C, Legori A, Lembo S, Loconsole F, Malagoli P, Marzano AV, Mercuri SR, Megna M, Micali G, Mortato E, Musumeci ML, Narcisi A, Offidani AM, Orsini D, Paolino G, Pellacani G, Peris K, Potenza C, Prignano F, Quaglino P, Ribero S, Richetta AG, Romanelli M, Rossi A, Strippoli D, Trovato E, Venturini M, Bianchi L. Campione E, et al. Among authors: fiorella c. Pharmaceuticals (Basel). 2024 Oct 16;17(10):1378. doi: 10.3390/ph17101378. Pharmaceuticals (Basel). 2024. PMID: 39459016 Free PMC article.
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis).
Orsini D, Megna M, Assorgi C, Balato A, Balestri R, Bernardini N, Bettacchi A, Bianchelli T, Bianchi L, Buggiani G, Burlando M, Brunasso A, Caldarola G, Cameli N, Campanati A, Campione E, Carugno A, Chersi K, Conti A, Costanzo A, Cozzani E, Cuccia A, D'Amico D, Dal Bello G, Dall'Olio EG, Dapavo P, De Simone C, Di Brizzi EV, Di Cesare A, Dini V, Esposito M, Errichetti E, Fargnoli MC, Fiorella CS, Foti A, Fratton Z, Gaiani FM, Gisondi P, Giuffrida R, Giunta A, Guarneri C, Legori A, Loconsole F, Malagoli P, Narcisi A, Paolinelli M, Potestio L, Prignano F, Rech G, Rossi A, Skroza N, Trovato F, Venturini M, Richetta AG, Pellacani G, Dattola A. Orsini D, et al. Among authors: fiorella cs. J Dermatolog Treat. 2024 Dec;35(1):2393376. doi: 10.1080/09546634.2024.2393376. Epub 2024 Aug 20. J Dermatolog Treat. 2024. PMID: 39164008 Free article.
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis).
Orsini D, Graceffa D, Burlando M, Campanati A, Campione E, Guarneri C, Narcisi A, Pella P, Romita P, Travaglini M, Zichichi L, Arancio LMH, Assorgi C, Baggini G, Balestri R, Bianchelli T, Bianchi L, Brunasso AMG, Cagni AE, Caldarola G, Calianno G, Carpentieri A, Carriero M, Carugno A, Cona F, Costanzo A, Cozzani EC, Dal Bello G, Dattola A, Donnarumma M, De Col E, Esposito M, Fiorella CS, Galluzzo M, Graziola F, Lazzaro Danzuso GC, Licata G, Licciardello M, Legori A, Malagoli P, Mola F, Moretta G, Muracchioli A, Musumeci A, Musumeci ML, Pagnanelli G, Panasiti V, Peterle L, Provenzano E, Rubatto M, Sarno O, Strippoli D, Vaira F, Fargnoli MC. Orsini D, et al. Among authors: fiorella cs. Clin Exp Dermatol. 2025 Jul 24;50(8):1667-1669. doi: 10.1093/ced/llaf168. Clin Exp Dermatol. 2025. PMID: 40233156 No abstract available.
Effectiveness, speed of action and safety of brodalumab in elderly psoriasis patients: a multicenter real-world study - IL PSO (Italian Landscape Psoriasis).
Orsini D, Graceffa D, Burlando M, Campanati A, Campione E, Guarneri C, Narcisi A, Pella P, Romita P, Travaglini M, Zichichi L, Arancio LMH, Baggini G, Balestri R, Bianchi L, Brunasso AMG, Cagni AE, Caldarola G, Calianno G, Carpentieri A, Carriero M, Carugno A, Cona F, Costanzo A, Cozzani E, Dal Bello G, Lazzaro Danzuso GC, Dattola A, Di Tano A, Diotallevi F, Donnarumma M, De Col E, Esposito M, Fiorella CS, Galluzzo M, Graziola F, Licciardello M, Legori A, Malagoli P, Mola F, Moretta G, Muracchioli A, Musumeci A, Musumeci ML, Pagnanelli G, Panasiti V, Provenzano E, Rizzo D, Rubatto M, Sarno O, Strippoli D, Vaira F, Fargnoli MC. Orsini D, et al. Among authors: fiorella cs. J Dermatolog Treat. 2025 Dec;36(1):2452948. doi: 10.1080/09546634.2025.2452948. Epub 2025 Feb 6. J Dermatolog Treat. 2025. PMID: 39914798 Free article. No abstract available.
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: a 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis).
Megna M, Orsini D, Assorgi C, Balato A, Balestri R, Bianchi L, Brianti P, Brunasso G, Buononato D, Burlando M, Cagni AE, Caldarola G, Cameli N, Campanati A, Campione E, Carrera CG, Carugno A, Chersi K, Costanzo A, Cusano F, D'Amico D, Dal Bello G, Dapavo P, Dattola A, De Simone C, Di Lernia V, Dini V, Errichetti E, Esposito M, Fargnoli MC, Fiorella CS, Foti A, Gaiani FM, Gargiulo L, Gatti A, Gisondi P, Giunta A, Ibba L, Lasagni C, Loconsole F, Maione V, Malagoli P, Marzano AV, Maurelli M, Mercuri SR, Michelerio A, Michelucci A, Morrone P, Mortato E, Narcisi A, Offidani A, Paolino G, Parodi A, Pellacani G, Quaglino P, Richetta AG, Romano F, Sena P, Trevisan G, Uzzauto MT, Venturini M, Potestio L. Megna M, et al. Among authors: fiorella cs. Clin Exp Dermatol. 2025 Mar 26;50(4):858-859. doi: 10.1093/ced/llae400. Clin Exp Dermatol. 2025. PMID: 39373543 No abstract available.
Effectiveness of Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: A Retrospective, Real-World Multicenter Study with a Focus on Obese and Multi-Failure Patients-IL PSO (Italian Landscape Psoriasis).
Orsini D, Graceffa D, Burlando M, Campanati A, Campione E, Guarneri C, Narcisi A, Pella P, Romita P, Travaglini M, Zichichi L, Arancio LMH, Baggini G, Balestri R, Bianchelli T, Bianchi L, Brunasso AMG, Cagni AE, Caldarola G, Calianno G, Carpentieri A, Carriero M, Carugno A, Cona F, Costanzo A, Cozzani EC, Dal Bello G, Danzuso GCL, Dattola A, Donnarumma M, De Col E, Esposito M, Fiorella CS, Galluzzo M, Graziola F, Licata G, Licciardello M, Legori A, Malagoli P, Mola F, Moretta G, Muracchioli A, Musumeci A, Musumeci ML, Pagnanelli G, Panasiti V, Peterle L, Provenzano E, Rubatto M, Sarno O, Strippoli D, Vaira F, Fargnoli MC. Orsini D, et al. Among authors: fiorella cs. J Clin Med. 2025 Feb 8;14(4):1087. doi: 10.3390/jcm14041087. J Clin Med. 2025. PMID: 40004618 Free PMC article.
Upadacitinib is efficacious in reducing the alexithymic trait in adult patients with moderate-to-severe atopic dermatitis: a prospective multicenter real-life study.
Nettis E, Cristallo M, Fiorella CS, Giuliani A, Patella V, Pierro L, Peduto T, Amoruso GF, Scotto DI Luzio G, Morrone P, Carriero M, DE Giacomo P, Triggiani M, Carrieri I, Zaza I, Pugliese F, Castriota M, Pellè S. Nettis E, et al. Among authors: fiorella cs. Ital J Dermatol Venerol. 2025 Oct;160(5):398-405. doi: 10.23736/S2784-8671.25.08228-3. Ital J Dermatol Venerol. 2025. PMID: 41041873 Free article.
18 results